Skip to content
Dx

ICD-10-PCS 2027 procedure code

3E0P7GCIntroduction of Other Therapeutic Substance into Female Reproductive, Via Natural or Artificial Opening

✓ Valid for 2027Female only

Short description: Introduce of Oth Therap Subst into Fem Reprod, Via Opening

Code unchanged since ICD-10-PCS took effect on October 1, 2015. Source: official FY2027 ICD-10-PCS release from CMS. Page updated September 29, 2026. About our data

About 3E0P7GC

3E0P7GC is the ICD-10-PCS code for a introduction procedure on the female reproductive using a via natural or artificial opening approach with other therapeutic substance (qualifier: other substance). In ICD-10-PCS, introduction means putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products.

In plain terms, this corresponds to Insufflation of therapeutic agent into fallopian tubes, the ICD-9-CM procedure title it maps to (66.95).

For a different body part, codes include 3E097GC (nose), 3E0B7GC (ear), 3E0C7GC (eye), 3E0D7GC (mouth and pharynx), 3E0E7GC (products of conception), 3E0F7GC (respiratory tract) and 5 more.

The same procedure with a different approach is coded 3E0P3GC (percutaneous), 3E0P4GC (percutaneous endoscopic) and 3E0P8GC (via natural or artificial opening endoscopic).

It doesn't appear in the MS-DRG procedure index, so on its own it doesn't change the DRG assignment.

It has been valid since ICD-10-PCS took effect on October 1, 2015.

What each character means

1. Section
3Administration
2. Body System
EPhysiological Systems and Anatomical Regions
3. Operation
0Introduction

Putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products

4. Body System / Region
PFemale Reproductive
5. Approach
7Via Natural or Artificial Opening

Entry of instrumentation through a natural or artificial external opening to reach the site of the procedure

6. Substance
GOther Therapeutic Substance

Includes: Anacaulase-bcdb; Bromelain-enriched Proteolytic Enzyme; Collagenase SANTYL Ointment; COSELA(tm) (Trilaciclib); ENSPRYNG(tm) (Satralizumab-mwge); Fostamatinib; Idarucizumab, Pradaxa(R)(dabigatran) reversal agent; NexoBrid(tm); Praxbind(R) (idarucizumab), Pradaxa(R)(dabigatran) reversal agent; SANTYL Ointment; Satralizumab-mwge; TAVALISSE(R); Trilaciclib

7. Qualifier
COther Substance

Other versions of this procedure

ICD-9-CM equivalent

Converter →
  • 66.95Insufflation of therapeutic agent into fallopian tubesapproximate

From the CMS 2018 General Equivalence Mappings (GEMs), the final GEMs release.

Code history

  1. 2016
  2. 2017
  3. 2018
  4. 2019
  5. 2020
  6. 2021
  7. 2022
  8. 2023
  9. 2024
  10. 2025
  11. 2026
  12. 2027
  • FY2016 (effective 10/1/2015): Added (first year of ICD-10-CM)
  • No changes since FY2016.

Common questions about 3E0P7GC

Is 3E0P7GC a valid ICD-10-PCS code for 2027?

Yes. 3E0P7GC is valid for inpatient procedures from October 1, 2026 through September 30, 2027.

What is the ICD-9 procedure code for 3E0P7GC?

The CMS GEMs map 3E0P7GC to ICD-9-CM 66.95 (Insufflation of therapeutic agent into fallopian tubes).